Dovato
Transitions From Daily Dovato to Long-Acting Cabenuva Wanted by Patients With HIV
Many people with HIV want to transition from viral suppression with daily oral Dovato to long-acting injectable ...
JULY 23, 2025
Study Finds 1 INSTI Combo Fares Better With Weight Gain
How do you pick which drug to prescribe for your patients with HIV?
MARCH 26, 2025
For Advanced HIV, 2-Drug Dovato Regimen as Effective as 3 Drugs
The two-drug regimen of dolutegravir-lamivudine achieves comparable efficacy to three-drug therapy regimens in ...
MARCH 21, 2025
FDA Grants New Indication for Dovato to Treat Adolescents 12 and Older
The FDA granted a new indication for Dovato to treat HIV-1 infection in adolescents 12 years of age and older and ...
APRIL 10, 2024
FDA Approves Dovato—First 2-Drug Complete Regimen for HIV
Dovato is a single table regimen containingdolutegravir-lamivudine and is approved as a complete regimen for the ...
APRIL 8, 2019
